Scientists step closer to drug treatment for hepatitis B

June 19, 2017
Electron micrograph of hepatitis B virus. Credit: Centers for Disease Control and Prevention

A major new insight into how Hepatitis B Virus works could pave the way for new drug treatments for the infection which is the major cause of liver cancer worldwide.

The team at the Universities of York and Leeds identified an "assembly code" in the of Hepatitis B Virus that allows it to create a protective casing in which it can produce new infectious particles.

They found that the signal, generated by ribonucleic acid (RNA), helps to overcome an 'engineering problem', assembling them into in a particular geometric pattern.

Professor Reidun Twarock, mathematical biologist at the University of York's Department of Mathematics and Biology, said: "It is a bit like the chain on a bicycle. If we don't assemble the chain on the sprockets, it becomes tangled and won't function. Once assembled correctly, it connects the pedals with the wheels allowing the component parts to work together."

"We see the same process happening between the Hepatitis B RNA signals and the viral proteins. The proteins are attracted by these signals, which then promote their assembly into a precise molecular machine that allows the virus to produce a DNA copy of its genetic material and hence become infectious."

The virus is transmitted through blood and bodily fluids. It is thought that more than two billion people have been infected worldwide, and around 350 million people remain carriers of the infection, which can, over time, result in their deaths.

The virus occurs in Europe but is much more common in parts of Asia, especially China and Africa. There are more than one million infected people in the USA where treatments can include expensive drugs and even liver transplantation.

Professor Peter Stockley, a structural virologist from the University of Leeds Astbury Centre, said: "There is a vaccine for the virus, but once you have the condition there is no treatment, other than drugs that can reduce symptoms but not change the long-term outlook.

"We often compare the disease to HIV due to the way in which the virus is passed from person-to-person, but unlike HIV there are no effective drugs to improve quality of life outcomes. Now that we know how the virus assembles, we can interrupt the interactions with the RNA signals—a bit like when a twig catches the sprocket on a bike, knocking the chain off."

The researchers are already collaborating with a team at the National Institutes of Health in the USA to identify potential candidates that are capable of breaking the link between RNA and proteins which should halt viral replication.

The research was funded by The Wellcome Trust, the Medical Research Council, and the Universities of Leeds and York, and is published in the journal Nature Microbiology.

Explore further: Scientists close in on cracking 'Enigma Code' of common cold

More information: HBV RNA pre-genome encodes specific motifs that mediate interactions with the viral core protein that promote nucleocapsid assembly, Nature Microbiology (2017). DOI: 10.1038/nmicrobiol.2017.98

Related Stories

Scientists close in on cracking 'Enigma Code' of common cold

February 23, 2017
Scientists at the Universities of York, Leeds, and Helsinki say they are a step closer to cracking, what researchers have dubbed, the 'Enigma Code' of the common cold virus.

Genetic study reveals how hepatitis C interacts with humans

April 11, 2017
A big data study of hepatitis C and more than 500 patients with the virus has opened the way for a better understanding of how the virus interacts with its human hosts.

Cases of hepatitis B and C hit 325 million: WHO

April 21, 2017
An estimated 325 million people are living with hepatitis B or C and few are aware of their condition, with death tolls from the viruses rising, the UN said Friday.

Zika virus protein mapped to speed search for cure

March 27, 2017
A study published today shows how Indiana University scientists are speeding the path to new treatments for the Zika virus, an infectious disease linked to birth defects in infants in South and Central America and the United ...

Team identifies how hepatitis A virus causes liver injury

September 15, 2016
Hepatitis researchers have long thought that immune cells sent by the body to attack virus-infected cells in the liver cause the acute liver injury associated with hepatitis A virus (HAV) and other hepatitis viruses. Yet, ...

Recommended for you

Researcher identifies a new way to treat HIV

August 24, 2017
Medical treatment that targets human proteins rather than ever-mutating viruses may one day help HIV-positive people whose bodies have built a resistance to "cocktails" currently used to keep them healthy, according to a ...

New insights into the world of trypanosomes

August 23, 2017
Single specimens of the vermicular pathogens causing sleeping sickness swim inside the gut of the tsetse fly between blood cells which the fly has ingested from an infected mammal. This is where they start their week-long ...

Survey of DNA fragments circulating in the blood suggests vast microbial diversity

August 23, 2017
A new survey of DNA fragments circulating in human blood suggests our bodies contain vastly more diverse microbes than anyone previously understood. What's more, the overwhelming majority of those microbes have never been ...

Study a breakthrough in understanding chronic pain in children

August 23, 2017
A University of Calgary psychologist who studies pediatric pain has made a breakthrough in understanding the cause of chronic pain in adolescents—by focusing on those recovering from major surgeries.

Scientists develop infection model for tickborne flaviviruses

August 22, 2017
National Institutes of Health (NIH) scientists have filled a research gap by developing a laboratory model to study ticks that transmit flaviviruses, such as Powassan virus. Powassan virus was implicated in the death of a ...

Zika virus stifles pregnant women's weakened immune system to harm baby, study finds

August 21, 2017
The Zika virus, linked to congenital birth defects and miscarriages, suppresses a pregnant woman's immune system, enabling the virus to spread and increasing the chances an unborn baby will be harmed, a Keck School of Medicine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.